Market Closed - Swiss Exchange 11:30:38 2024-04-18 am EDT 5-day change 1st Jan Change
72.12 CHF +0.17% Intraday chart for Alcon Inc. -3.61% +9.87%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Alcon Announces Management Changes CI
Alcon’s Medical Chief to Retire; Successor Named MT
Alcon Inc. Launches Clareon Presbyopia Correcting IOLs in India CI
UBS Boosts Alcon PT, Affirms Buy Rating MT
ALCON : price target raised by UBS CF
Argus Raises Alcon's Price Target to $100 From $90, Maintains Buy Rating MT
Mizuho Securities Raises Price Target on Alcon to $100 From $95, Maintains Buy Rating MT
Cooper Companies lifts annual revenue forecast on strong contact lens demand RE
Needham Raises Alcon's PT to $98 From $86 After 'Solid' Q4 2023 Results, Above-Consensus 2024 Guidance; Keeps Buy Rating MT
Swiss Market Index Extends Losses; Alcon Shines MT
Global markets live: Reckitt, Apple, Warner, Eli Llily, Intel... Our Logo
Transcript : Alcon Inc., Q4 2023 Earnings Call, Feb 28, 2024
ALCON : Despite the slight Q4 miss, the markets cheered the 2024 guidance Alphavalue
Alcon Posts Rise in FY23 Net Income, Revenue MT
Alcon Q4 Core Earnings, Sales Rise; 2024 Guidance Issued, 2023 Dividend Proposed MT
(ALC) ALCON Expects Fiscal Year 2024 EPS Range $3.00 - $3.10 MT
Earnings Flash (ALC) ALCON Reports Q4 Revenue $2.35B MT
Alcon Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (ALC) ALCON Posts Q4 EPS $0.70 MT
Alcon Inc. Proposes Dividend for the Year 2023, Payable on or Around May 16, 2024 CI
Alcon Inc. Provides Earnings Guidance for the Year 2024 CI
Alcon Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
KeyBanc Initiates Alcon at Overweight Rating With $87 Price Target MT
Bernstein Initiates Alcon at Outperform With $94.40 Price Target MT
Transcript : Alcon Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM
Chart Alcon Inc.
More charts
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
78.94 USD
Average target price
93.35 USD
Spread / Average Target
+18.26%
Consensus
  1. Stock Market
  2. Equities
  3. ALC Stock
  4. News Alcon Inc.
  5. Alcon : AlphaValue/Baader Europe Lifts Price Target on Alcon, Maintains Add Recommendation